Sihuan Pharmaceutical Holdings Group Ltd.
SHPHF
Updated: 23/09/2026, 17:04:35
Sihuan Pharmaceutical Holdings Group Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. The Medical Aesthetic Products refers to the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care and others to provide non- or minimally invasive medical aesthetics comprehensive solutions. The company was founded by Feng Sheng Che and Wei Cheng Guo in 2001 and is headquartered in Beijing, China.
No summaries found.
- Share price
- $0.12
- Market cap
- $1.09B
- Exchange
- OTC
- Currency
- USD
- CEO
- Wei Cheng Guo
- Employees
- 2,843
- IPO date
- 13/01/2012
- Beta
- 0.894
- Last dividend
- $0.00
- Day range
- $0.12 – $0.12
- 52-week range
- $0.05 – $0.21
- 1-day performance
- 0.00%
- 1-year performance
- 143.90%
- Current drawdown (1Y)
- -42.94%
- CIK
- N/A
- CUSIP
- G8162K113
- ISIN
- BMG8162K1137
- Created
- 07/12/2025, 14:13:25
- Last update
- 23/09/2026, 17:04:35
Track Sihuan Pharmaceutical Holdings Group Ltd. with an AI analyst
See which prediction-market events move SHPHF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.